chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient awoke with large, swollen, red nodule 3 inches across from site of injection that was warm to the touch - marked area with sharpie on day 1 and took 1000 mg of Tylenol along with cool compresses to site. On day 2, redness had spread beyond borders another half inch with reduced swelling - took 1000 mg Tylenol and cool compresses according to instructions given by PA with advisement to follow up for suspected cellulitis if not improved by 3rd day. Redness and swelling markedly decreased over the next 2 days. Soreness still present on day 4.
Systemic: Body Aches Generalized-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Headache-Medium, Systemic: Tingling (specify: facial area, extemities)-Medium, Additional Details: extremely idzzy/ligh headed tingling sensation all over body, weakness
This case was reported by a pharmacist via call center representative and described the occurrence of chills in a 62-year-old female patient who received SHINGRIX for prophylaxis. On 29th May 2018, the patient received the 2nd dose of SHINGRIX (intramuscular). On 29th May 2018, less than a day after receiving SHINGRIX, the patient experienced chills. On an unknown date, the outcome of the chills was recovered/resolved. The reporter considered the chills to be possibly related to SHINGRIX. Additional details were provided as follows: The patient received the SHINGRIX vaccine in the left arm before the lunch. The same day, at night, the patient experienced chills. The symptoms resolved at that night.  The suspect vaccine lot number and expiry date was not available. This case is one of the 5 cases, reported by the same reporter. The caller stated that they administered about 70 SHINGRIX doses in their pharmacy.
7 days after receiving second dose, patient developed diffuse headache, which then settled in occipital region. He had 3 episodes , the last of which was still present the day after it developed. Headache more noticeable with physical activity, and usually began after he finished lifting weights.
Attendee received first dose Pfizer vaccine at 12:26 pm in the left arm.  Lot# EW0170. Attendee was directed to observation area.   At 12:36 sitting in the observation area in a tripod position and lost consciousness and stumped against the admin, who had come over to check on him.  Loss of consciousness x 15 seconds.  Attendee assisted to the cot to lie down, as was now completely awake and sitting in semi  fowler position on the cot.  A little bit confused, diaphoretic and pale.  Voiced complaints of dizziness. Icepack applied to the neck.  12:38  No longer confused.  Refusing 911 to be called.   HR:  54   BP:  110/60   RR:   20   O2Sat%:  100
09/02/22 presents to EC ED for "fatigue and fever". PMHx of "CAD, HTN"
A patient exceeded her second dose beyond 42 days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (A patient exceeded her second dose beyond 42 days) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (A patient exceeded her second dose beyond 42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (A patient exceeded her second dose beyond 42 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  No treatment information was provided.
Flushing/sweating, dizziness, and lightheaded. BPs 149/89 (pulse 83), 137/87 (pulse 87). O2 sats 98%, 99%.
had syncopal episode @ school, p/receiving vax 28NOV94 & 09DEC94; found w/in 2 mins to be apnic w/no carotid pulse; CPR done by school nurse almost immed; sent to hosp, ped ICU pt expired 3JAN95;
As the pt was driving home after her flu shot, her nose started running, throat and chest got sore and tight. The next morning, her throat and chest so tight it was difficult to breath.
large induration/ indurated middle; pruritus; erythema; pain; target rash; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE INDURATION (large induration/ indurated middle), VACCINATION SITE PRURITUS (pruritus), VACCINATION SITE ERYTHEMA (erythema), VACCINATION SITE PAIN (pain) and VACCINATION SITE RASH (target rash) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INDURATION (large induration/ indurated middle), VACCINATION SITE PRURITUS (pruritus), VACCINATION SITE ERYTHEMA (erythema), VACCINATION SITE PAIN (pain) and VACCINATION SITE RASH (target rash). At the time of the report, VACCINATION SITE INDURATION (large induration/ indurated middle), VACCINATION SITE PRURITUS (pruritus), VACCINATION SITE ERYTHEMA (erythema), VACCINATION SITE PAIN (pain) and VACCINATION SITE RASH (target rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: follow up received on 10-may -2021 and does not contain any significant information
The vaccination was administered inappropriately based on current CDC guidelines. Adult booster dose of the Pfizer COVID-19 vaccine was given to the patient, aged 13, at the time of injection. I spoke to the patient's mother around 5:00pm and she states that the patient feels fine. She will monitor him closely for any adverse events. Mother was notified to call pharmacy with any questions or concerns.
Chest pain, sinking feeling, shortness of breath,.  It lasted for 1/2 a day
Red, slightly raised area at the injection site. Warm to touch and patient complained of itching. Diameter measured 2 inches.
The CVS staff was highly professional. No issues, they were courteous and explained everything thoroughly and told me to sit and wait to monitor me after I received both the flu shot and the 3rd Pfizer booster vaccines. I decided to get the 3rd  Pfizer vaccine because my BMI puts me into the ?overweight? range but not the ?obese? range and it has been 6 months since my second dose. Despite this ?adverse? event, I would still elect to get the third vaccine dose anyway. Just want to be clear about that.  I didn?t have any reaction ever before with a flu vaccine or the first two rounds of the Pfizer vaccine, and the clinic seemed busy so I waited a few minutes before departing.  I got into the car and began to drive home. My throat seemed to feel like I had something stuck in it or like it was slightly closing up. I think this made me nervous or something and my heart rate started increasing. The throat closing up never closed up fully, I was always able to breath and I was just breathing a bit more quickly. I pulled off to the side of the road and stepped out of my car with my cell phone at a nearby gas station located at  At 2:39p EDT, I called 911 by cellphone, based on my phone history. I talked to the man on the phone and explained I?ve never experienced anything like this before. I was in the military and have flown planes before and my heart never raced this fast even when doing power off stalls and stalling the plane. I?m scared of heights if that makes any difference, needless to say I didn?t stay in the aviation field for long. I told him I think I had a panic attack or something because I never have had any reaction to medicine nor reactions to the dozens of vaccines I?ve had over my lifetime. Being on the phone with him made me call down enough over a period of 2-3 minutes to where I told him I didn?t need an ambulance dispatched. I sat in the car and drank water, talking to my girlfriend on the phone for a while till the symptoms went away.  By about 2:48p the symptoms had mostly subsided except for feeling a little nervous.
Day after the injection the area around the site became reddened, gradually worsening daily until the redness was 3.5" long x 4" wide,  L arm was swollen from the shoulder to fingertips, and the arm was painful with limited ROM.  Redness began to fade after 3 weeks; L arm remains swollen and painful.  Pt was evaluated by the MD on 5/18/21 and was advised to hold off on 2nd vaccine (scheduled for 5/25/21)  MD will decide if/when 2nd vaccine will be administered.
Immediately after vaccine was given on 9-6-16, patient experienced ringing in both ears. Intermittent. Patient states he had headache from hitting his head on 9/3 (prior to vaccines) but denies ringing in ears prior to vaccine, specifically HPV.
Immediately after immunization was received a shooting pain would radiate down to fingers. Pt states a decreased range of motion in right arm as well as decreased strength.
Patient received shingles (ZOSTAVAX) injection on 7/8/10 and noticed swelling and rash at site of injection, 2 days later she also noticed shingles rash at another location.
cough; This spontaneous case was reported by a non-health professional and describes the occurrence of COUGH (cough) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COUGH (cough). At the time of the report, COUGH (cough) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no treatment details reported. no concomitant details reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-068381 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-068381:wife case
A report has  been received from a Health Professional concerning a child, subject of unknown gender, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. The patient experienced BREAKTHROUGH CASES OF FLUMIST. The outcome of the event of BREAKTHROUGH CASES OF FLUMIST is unknown. The report was considered to be non-serious.
while receiving vax pt mouth opened & held breath no audible cry & became limp; MD summoned vital signs stable became arousable was still groggy-observed for a while-discharged home; f/u 1 day later; no fever-active as nl;
She had been suffered from dizziness, shortness of breath,  fatigue,  weight loss, wasy bruising, and then she was diagnoised to Acute Lymphoblastic Leukemia on September 14, 2021.  After that, she was treated at Hospital However,  my wife passed away on Oct 11, 2021. She was healthy and eated healthy food and worked out regularly.  She had never been exposed to any risky environment.  Only potential factor is COVID vaccination.
Deltoid muscle swollen, mildly warm and painful 12 - 24 hours post vaccination.  Pain severe enough to wake him and require a phone call to on call MD
I scheduled my nephew's Pfizer Dose # 1 and Dose # 2 appointments on Pharmacy's web site today on Wed 12/28/22. I then received an e-mail with a Confirmation. The appointment time was 3:00 PM for his 1st COVID-19 Dose # 1. We reached Pharmacy before 3 PM. This was a minute drive from our house. We had to get in the line. We were finally given a form to fill out at 3:54 PM. I filled out the form. We had to wait again. The pharmacist rushed and instructed us to come to the room. Without confirming 'Section D: Complete BEFORE Vaccine Administration' on the form. She also did not completed the 'Section E: Complete DURING the Patient Interaction' on the form. She asked both of us to put masks on and gave us masks. She gave the shot to him, then asked for the card. I asked her, "The insurance card?". She responded, "No, the COVID card." I then said, "We actually need one." I also have a video of this event. She looked shocked and confused at that time. I advised her the appointment was for the Dose # 1 and not a Booster Shot. She gave a Booster Shot to him without checking the appointment. She did not even look at the form. I requested to speak with the manager. They pharmacy manager was off duty. The store manager, was called by an announcement. She had an attitude and was very rude. She refused to talk until she talked to the pharmacist. They were discussing it out in the front. Others could hear them too. The tech, who registered him. They were short-staffed and very unprofessional. There was a lengthy wait-time. I asked her why this mistake happened and why didn't she look at the system and the form? He is a minor and under 18. He never had the Dose # 1. He is traveling with grandparents or parents end of January and needs to get this done.
Vaccine received on Friday 9-4 2PM - 9-18 PM - taste buds were gone - increased hearing in left ear. Sat 9-19 woke up with left side of face drooping and numb. Eye, mouth drooping - couldn't close left eye - Sawn general physician on Tues 9-22 - Rx VALTREX and Prednisone - 2nd course of Prednisone - still no resolution of symptoms. Saw my Lyme Dr. on 10-8 (Also saw ophthalmologist for eye).
When attempting to donate whole blood on 10/18/2021, I was rejected due to low iron. When I next went in to donate blood on 11/29/2021, my iron level was back to normal and sufficient for donation. I think this low iron was not a coincidence, since the same thing happened after my first COVID-19 vaccine, which I received on 3/15/2021. I went in to donate blood a week later on 3/22/2021  and my iron was low. When I next attempted to donate blood on 8/18/2021, my iron level was back to normal.
pt recv vax in 1992 & exp an autoimmune rxn in 1994 which consisted of rheumatoid arthritis & hair loss; sx were worsening @ the time of the report; no further details were provided;
High blood sugar after the vaccine; Sweating; Shaky; Hot feeling; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (High blood sugar after the vaccine), HYPERHIDROSIS (Sweating), TREMOR (Shaky) and FEELING HOT (Hot feeling) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21-2A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DULAGLUTIDE (TRULICITY), GLIPIZIDE and METFORMIN for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced HYPERGLYCAEMIA (High blood sugar after the vaccine), HYPERHIDROSIS (Sweating), TREMOR (Shaky) and FEELING HOT (Hot feeling). The patient was treated with DULAGLUTIDE (TRULICITY) at a dose of once a week; GLIPIZIDE at a dose of 10 mg twice a day and METFORMIN at a dose of 1000 mg twice a day. At the time of the report, HYPERGLYCAEMIA (High blood sugar after the vaccine) had not resolved and HYPERHIDROSIS (Sweating), TREMOR (Shaky) and FEELING HOT (Hot feeling) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Mar-2021, Blood glucose increased: 292 (High) Blood sugar 292 and 201 (High) Blood sugar 201. On 24-Mar-2021, Blood glucose increased: 234 (High) Blood sugar 234. On an unknown date, Blood glucose increased: 151 (High) Blood sugar 151 and 357 (High) Blood sugar 357.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
We are wanting to get our sceond dose we had our original April 19"; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (We are wanting to get our sceond dose we had our original April 19") in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (We are wanting to get our sceond dose we had our original April 19"). At the time of the report, PRODUCT DOSE OMISSION ISSUE (We are wanting to get our sceond dose we had our original April 19") had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not provided.  Treatment medication was not provided.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments
expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired vaccine used) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired vaccine used). On 11-Jan-2022, EXPIRED PRODUCT ADMINISTERED (expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. No treatment information was provided. it was reported that some patients experienced Flu like symptoms.
This case was reported by a pharmacist via call center representative and described the occurrence of asthma aggravated in a adult male patient who received SHINGRIX (batch number C523T, expiry date unknown). Concurrent medical conditions included asthma. On 13th April 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. On 14th April 2018, 1 days after receiving SHINGRIX, the patient experienced asthma aggravated (serious criteria other: as per reporter). The patient was treated with prednisone. On an unknown date, the outcome of the asthma aggravated was unknown. It was unknown if the reporter considered the asthma aggravated to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient received SHINGRIX vaccine on left deltoid. The patient started having trouble with his asthma and started taking Prednisone. The patient took 40 mg prednisone for 5 days. The reporter spoke with the patient and the patient stated he was better but the pharmacist did not know if that meant his condition had improved or resolved.
Allergic dermatitis with Rt upper arm redness;warm to touch, itchiness. Treatment: Tylenol 500mg, Benadryl 25mg ,Claritin 10mg
This spontaneous report has been received from a nurse referring to a patient of unknown age and gender. The patient previously received a dose of M-M-R II (dose, frequency and lot # not reported) on 01-MAY-2012 and a dose of PROQUAD (dose, frequency and lot# not reported) on 17-MAR-2015. On 19-SEP-2016 the patient was inadvertently vaccinated a dose with M-M-R II (dose, frequency and lot# not reported) (extra dose administered). No symptoms reported. Additional information has been requested.
Breakthrough case admission after 4 vaccines Moderna 1/28/21 lot# 028L20A;  Moderna 2/25/21 lot# 004M20A;  Moderna 11/10/21 lot# 033F21A;  MOderna 4/21/22 lot# FM9992
The vaccination  1/10/2021. 6 pm .I began  to have symptoms right after the 48 hour mark on 1/12/2021 at 8 pm . I?d be yeah begin having hot flashing episodes ( not menopausal ) with severe diaphoresis, I feel achy. On 1/13/2021 when I woke up for work I felt short of breath slightly, my lungs felt very heavy and congestion, when I arrived at work I started having a dry cough and runny nose and a slight sore throat.When I told my boss she had me thought the employee paperwork and I went to a Clinic
It caused a severe flare-up of my ulcerative colitis. My GI doctor told me it seemed like it was from the vaccine and that some other patients were experiencing the same thing. He told me to "give it a few weeks" to see if it would magically go away. I waited 2 weeks and continued to get worse (bad abdominal pain, stuck in the bathroom 12-15 hours a day, passing blood and mucous).
4 hours after the shot, I noticed that my left eyelid was a bit swollen. No pain or itchiness. Not sure when it began to swell. I didn't think much of it, until about 2 hours as I could feel that it was more swollen. I was with friends, they recommended benedryl. So, went and talked to a pharmacist. On the way there, back began to feel itchy (similar to when I have broken out in hives in the past when an allergic reaction starts). Pharmacist recommended 25 ml of liquid benedryl every 4-6 hours and increase to 30 ml if swelling remains. After 1-2 days, if still present to go to doctor. I already have a doc office visit early Monday morning.
I'm getting a lot of back pain/mild back and nerve pain; I'm getting a lot of back pain/mild back and nerve pain; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 51 year-old male patient received bnt162b2 (BNT162B2), administration date 12Mar2021 (Lot number: EN6955) at the age of 51 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: BACK PAIN (non-serious), NEURALGIA (non-serious) all with onset 2021, outcome "not recovered" and all described as "I'm getting a lot of back pain/mild back and nerve pain". The event "i'm getting a lot of back pain/mild back and nerve pain" and "i'm getting a lot of back pain/mild back and nerve pain" was evaluated at the physician office visit. Therapeutic measures were taken as a result of back pain, neuralgia.  Additional information: The patient had a question about after his shot symptoms. The patient took his two doses. After his first covid shot on 12Mar2021, he experienced mild back and nerve pain. He was interested to see if this was happening to other people or not, he did not know if this was a Pfizer thing. He was not admitted to the hospital due to events. No emergency room visit.  No follow-up attempts are possible. No further information is expected.
Hyperglycemia,headaches,fatigue,soreness at injection site,blurry vision
Patient was being monitored during her post-vaccination observation period. Patient reported feeling "a bit warm"  and flushed, patient's face appeared reddened at nose and forehead. Vital signs assessed at 13:19 BP 148/78, HR 101, O2 sat 97%,  and 13:32. BP 132/72, HR 98, O2 sat 97%. Patient denied any other signs or symptoms.  Patient monitored another 20 minutes. Reported flushed feeling resolved, DC'd home at 13:44 in no signs/symptoms of distress.
Information has been received from a consumer concerning her 22 year old daughter with no pertinent medical history and "tons of allergies to medication" who on an unknown date, was vaccinated with the three doses of GARDASIL (lot number not reported). Concomitant medication included an unspecified medication for migraine and birth control. The consumer reported that, on an unspecified date, her daughter was diagnosed with cervical dysplasia after receiving an abnormal PAP smear. Re-ran PAP and repeated biopsy were performed and they showed that cervical dysplasia still presented. The experience was treated with freezing. The patient sought an unspecified medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.